+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      In situ Estradiol and Progestin (R5020) Localization in the Vascularly Separated and Isolated Hypothalamus of the Rhesus Monkey

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          A neurosurgical procedure has been developed for vascular isolation of the hypothalamus-thalamus region of the rhesus monkey brain. Utilizing this preparation, the left and right halves of the hypothalamus were perfused simultaneously, but separately, with a dextran-blood solution. Radiolabeled steroids were directly perfused in the dextran-blood into either the left or right half of the hypothalamus. Studies with radiolabeled gonadal steroids indicate that the majority of the carotid circulation is confined to the hypothalamus-thalamus area in this brain preparation and the cross-circulation of labelled steroids between the left and right sides of the hypothalamus is less than 10%. The usefulness of the preparation is illustrated by an autoradiographic study of the in situ hypothalamic distribution of (<sup>3</sup>H)estradiol in ovariectomized rhesus monkeys and of the synthetic progestin (<sup>3</sup>H)R5020 in estrogen-primed, ovariectomized rhesus monkeys. The direct perfusion of the (<sup>3</sup>H) steroids into the hypothalamus greatly increases the sensitivity of such a study compared to systemic administration of the (<sup>3</sup>H) steroids. The perfusion of one-half of the hypothalamus with (<sup>3</sup>H) steroid and the other half with (<sup>3</sup>H)steroid plus radioinert steroids permits in 1 animal, acting as its own control, the examination of a saturable distribution of a gonadal steroid in the rhesus monkey hypothalamus.

          Related collections

          Author and article information

          S. Karger AG
          26 March 2008
          : 32
          : 4
          : 202-208
          aDepartment of Reproductive Biology, Case Western Reserve University School of Medicine, and bBrain Research Laboratories, Division of Neurosurgery, Cleveland Metropolitan General Hospital, Cleveland, Ohio, USA
          123159 Neuroendocrinology 1981;32:202–208
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Original Paper


          Comment on this article